MENU
VRCA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verrica Pharmaceuticals (VRCA) Earnings Date & Reports

A.I. Advisor
published Earnings

VRCA is expected to report earnings to fall 28.35% to -30 cents per share on February 27

Verrica Pharmaceuticals VRCA Stock Earnings Reports
Q4'24
Est.
$-0.31
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.03
The last earnings report on November 04 showed earnings per share of -43 cents, missing the estimate of -37 cents. With 449.08K shares outstanding, the current market capitalization sits at 39.37M.
View a ticker or compare two or three
VRCA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
44 West Gay Street
Phone
+1 484 453-3300
Employees
100
Web
https://www.verrica.com